Pharmabiz1d
EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease
In addition, the secondary endpoint from the AD Cooperative Study-Activities of Daily Living Scale for Mild Cognitive Impairment (ADCS-MCI-ADL), which measures information provided by people caring ...
Le Lézard3d
CHMP issues positive recommendation for approval of lecanemab in the EU
BioArctic AB (publ) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic's partner Eisai's marketing authorization ...
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting
Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.
GEN11d
Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.
Forbes16d
International Money Transfer: Best Ways To Send Money Internationally
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Remittances are increasingly popular, rising by 3.8% in ...
U.S. News & World Report16d
23 Best Things To Do in Portland, OR
Courtesy of Photo by Matt Payne of Durango, Colorado|Getty Images Many critics, travelers and locals agree that of all of Portland's parks (and they are numerous), Washington Park is perhaps the ...
PC Magazine16d
How to Use Apple's Built-In Translate App as Your Personal Translator
Need to translate speech or text on the go? Several mobile apps can get the job done, but for those of you with an iPhone, iPad, or Apple Watch, Apple offers its own app. Unveiled with iOS 14, the ...
Morningstar17d
Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile
These data show that 46% of patients improved or had no decline, and 33% showed improvement from baseline on the CDR-SB, with similar results for ADAS-Cog14 and on the ADCS MCI-ADL scales.
Cambridge University Press17d
Hospital MCI Response Plan Analysis in a Low Resource Country After a Mass Casualty Incident: The Beirut Blast
Objective Mass casualty incidents (MCIs) come unannounced, mandating the immediate shift from the daily routine to crisis mode through the implementation of an MCI response plan (plan). On August 4, ...
Morningstar17d
Barings Corporate Investors MCI
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Nasdaq17d
Biogen/Eisai announce latest findings for Leqembi in Alzheimer’s disease
On the ADCS MCI-ADL, 51% of patients showed improvement or no decline and 48% showed improvement. These results – from no tau/low tau population and low amyloid populations – suggest that ...